IP Library Granted Patent US 11,453,883
Granted Patent B2
US 11,453,883 · App. 16/375,894 · Granted Sep 27, 2022

Display systems for proteins of interest

Inventor: Francisco Ylera (Munich, DE)
Assignee: BIO-RAD ABD SEROTEC GMBH
C12N15/70C07K16/241C07K16/32C07K19/00C12N7/00C12N15/1037C12N15/85C07K2317/21C07K2317/24C07K2317/55C12N2795/00051
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,453,883
App. No.
16/375,894
Granted
Sep 27, 2022
Kind
B2
Abstract

Described herein is a protein display selection method which uncouples a protein of interest (POI) library from the display selection system. Display of the POI can be achieved by forming a covalent bond between the POI and the anchor protein post expression either by enzymatic protein ligation (e.g. SpyLigase, SnoopLigase, sortase, butelase, peptiligase etc.) or by spontaneous covalent bond formation (e.g. SpyTag/SpyCatcher, SnoopTag/SnoopCatcher, etc.). The POI library is fused to a tethering sequence, for example SpyTag, at the C-terminus of the POI which then forms a covalent bond to a capture sequence found on an anchor protein, for example, the SpyCatcher-fused anchor protein, e.g., a SpyCatcher-geneIII protein (SpyCatcher-pIII) fusion, for the most common form of phage display. Nucleic acid constructs, host cell systems and methods of producing the protein display systems are also provided.

Claims (46)

1. A combination of vectors comprising:

a) a first vector comprising a genetic construct (GC1) comprising polynucleotide encoding a protein of interest (POI) fused, in frame, to a tether sequence; and

b) a second vector comprising a genetic construct (GC2) comprising polynucleotide encoding an anchor protein fused, in frame, to a capture sequence,

the tether sequence and capture sequence forming a covalent bond when brought into contact with one another either spontaneously or with the help of an enzyme; or

a combination of vectors comprising:

a) a first vector comprising a genetic construct (GC1) comprising polynucleotide encoding a protein of interest (POI) fused, in frame, to a capture sequence; and

b) a second vector comprising a genetic construct (GC2) comprising polynucleotide encoding an anchor protein fused, in frame, to a tether sequence,

the tether sequence and capture sequence forming a covalent bond when brought into contact with one another either spontaneously or with the help of an enzyme;

the POI being selected from antibodies, antibody fragments, single chain antibodies, scFv, scFab, or single domain antibodies and the anchor protein being selected from pIII, pVI, pVII, pVIII, or pIX.

2. The combination of vectors according to claim 1 , wherein each vector comprises transcriptional or translational control sequences for expressing the POI and anchor protein.

3. The combination of vectors according to claim 1 , wherein said transcription or translational control sequences are selected from replication origins, promoters, enhancers, repressor binding regions, transcription initiation sites, ribosome binding sites, translation initiation sites, and termination sites for transcription and translation.

4. The combination of vectors according to claim 1 , wherein said POI is selected from the group consisting of antibody fragments, single chain antibodies, scFv, scFab, and single domain antibodies.

5. The combination of vectors according to claim 2 , wherein:

a) the tethering sequence comprises SEQ ID NO: 27 or comprises a tethering sequence having at least 70% sequence identity to SEQ ID NO: 27 and the capture sequence comprises SEQ ID NO: 28 or a polypeptide having at least 70% identity to SEQ ID NO: 28;

b) the tethering sequence comprises between 5 and 50 consecutive amino acids of SEQ ID NO: 6, said tethering sequence including the aspartic acid residue at position 101 or a tethering sequence having at least 70% identity to said tethering sequence and the capture sequence comprises amino acids 22-137 of SEQ ID NO: 30; or

c) the tethering sequence comprises SEQ ID NO: 34 or a tethering sequence at least 70% identical thereto and the capture sequence comprises amino acids 22-137 of SEQ ID NO: 30.

6. The combination of vectors according to claim 1 , wherein said anchor protein is pIII.

7. A prokaryotic host cell comprising a combination of vectors according to claim 1 .

8. The combination of vectors according to claim 5 , wherein the tethering sequence comprises SEQ ID NO: 27 and the capture sequence comprises SEQ ID NO: 28.

9. The combination of vectors according to claim 5 , wherein the tethering sequence comprises between 5 and 50 consecutive amino acids of SEQ ID NO: 6 and includes the aspartic acid residue at position 101 and the capture sequence comprises amino acids 22-137 of SEQ ID NO: 30.

10. The combination of vectors according to claim 5 , wherein the tethering sequence comprises SEQ ID NO: 34 and the capture sequence comprises amino acids 22-137 of SEQ ID NO: 30.

11. The combination of vectors according to claim 1 , said combination of vectors comprising:

a) a first vector comprising a genetic construct (GC1) comprising polynucleotide encoding a protein of interest (POI) fused, in frame, to a tether sequence; and

b) a second vector comprising a genetic construct (GC2) comprising polynucleotide encoding an anchor protein fused, in frame, to a capture sequence,

the tether sequence and capture sequence forming a covalent bond when brought into contact with one another either spontaneously or with the help of an enzyme.

12. The combination of vectors according to claim 11 , wherein:

a) said first vector comprising a genetic construct (GC1) comprising polynucleotide encoding a protein of interest (POI) fused, in frame, to a tether sequence is an expression vector; and

b) said second vector comprising a genetic construct (GC2) comprising polynucleotide encoding an anchor protein fused, in frame, to a capture sequence is a helper vector.

13. The combination of vectors according to claim 12 , wherein the tethering sequence comprises SEQ ID NO: 27 and the capture sequence comprises SEQ ID NO: 28.

14. The combination of vectors according to claim 12 , wherein the tethering sequence comprises between 5 and 50 consecutive amino acids of SEQ ID NO: 6, said tethering sequence including the aspartic acid residue at position 101 or a tethering sequence having at least 70% identity to said tethering sequence and the capture sequence comprises amino acids 22-137 of SEQ ID NO: 30.

15. The combination of vectors according to claim 12 , wherein the tethering sequence comprises SEQ ID NO: 34 and the capture sequence comprises amino acids 22-137 of SEQ ID NO: 30.

16. The prokaryotic host cell according to claim 7 , said combination of vectors comprising:

a) a first vector comprising a genetic construct (GC1) comprising polynucleotide encoding a protein of interest (POI) fused, in frame, to a tether sequence; and

b) a second vector comprising a genetic construct (GC2) comprising polynucleotide encoding an anchor protein fused, in frame, to a capture sequence,

the tether sequence and capture sequence forming a covalent bond when brought into contact with one another either spontaneously or with the help of an enzyme.

17. The prokaryotic host cell according to claim 16 , wherein:

a) said first vector comprising a genetic construct (GC1) comprising polynucleotide encoding a protein of interest (POI) fused, in frame, to a tether sequence is an expression vector; and

b) said second vector comprising a genetic construct (GC2) comprising polynucleotide encoding an anchor protein fused, in frame, to a capture sequence is a helper vector that is integrated into the prokaryotic host cell genome.

18. The prokaryotic host cell according to claim 17 , wherein the tethering sequence comprises SEQ ID NO: 27 and the capture sequence comprises SEQ ID NO: 28.

19. The prokaryotic host cell according to claim 17 , wherein the tethering sequence comprises between 5 and 50 consecutive amino acids of SEQ ID NO: 6, said tethering sequence including the aspartic acid residue at position 101 or a tethering sequence having at least 70% identity to said tethering sequence and the capture sequence comprises amino acids 22-137 of SEQ ID NO: 30.

20. The prokaryotic host cell according to claim 17 , wherein the tethering sequence comprises SEQ ID NO: 34 and the capture sequence comprises amino acids 22-137 of SEQ ID NO: 30.

21. The combination of vectors according to claim 1 , said combination of vectors comprising:

a) a first vector comprising a genetic construct (GC1) comprising polynucleotide encoding a protein of interest (POI) fused, in frame, to a capture sequence; and

b) a second vector comprising a genetic construct (GC2) comprising polynucleotide encoding an anchor protein fused, in frame, to a tether sequence,

the tether sequence and capture sequence forming a covalent bond when brought into contact with one another either spontaneously or with the help of an enzyme;

the POI being selected from antibodies, antibody fragments, single chain antibodies, scFv, scFab, or single domain antibodies and the anchor protein being selected from pIII, pVI, pVII, pVIII, or pIX.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2019
From: YLERA, FRANCISCO
To: BIO-RAD ABD SEROTEC GMBH
Reel/Frame 048978/0182 →
Continuity (2)
Provisional Application 62652938 · Apr 5, 2018
Related Publication 20190309312A1 · Oct 10, 2019
Cited By (1)
US 12,188,023